CDX2 Expression Predicts Fluoropyrimidine Sensitivity Across Rare Non-GI Tumors: A Three-Case Series
Preprint
- 26 January 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Caudal type homeobox 2 (CDX2) is an intestine-specific transcription factor that serves as a diagnostic marker of enteric differentiation and may also reflect tumor behavior and therapeutic susceptibility. Emerging evidence suggests that CDX2 expression may predict sensitivity to fluoropyrimidine-based therapy independent of tissue of origin. We report a retrospective case series of three patients with metastatic adenocarcinoma (aggressive variant prostate, minor salivary gland, and intestinal-type sinonasal tract) exhibiting strong CDX2 nuclear expression. In all cases, tumors were refractory to or lacked established standard systemic therapy. Treatment decisions were guided by the CDX2-positive enteric phenotype, leading to the initiation of fluoropyrimidine-based regimens. Response was assessed using PET-CT and MRI. All three patients achieved marked metabolic and clinical responses, including a sustained complete metabolic response in the prostate cancer case and durable disease control in the salivary gland and sinonasal tumors. These findings highlight CDX2 as a clinically actionable biomarker that may identify tumors intrinsically susceptible to fluoropyrimidines regardless of anatomical origin. CDX2 immunohistochemistry is widely available and inexpensive, and may complement genomic profiling in rare malignancies or in settings where standard treatment algorithms are limited.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Use of SATB2 and CDX2 Immunohistochemistry to Characterize and Diagnose Colorectal CancerApplied Immunohistochemistry & Molecular Morphology, 2024
- CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expressionCell Death & Disease, 2019
- Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue MicroarraysLaboratory Investigation, 2003
- Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic miceBiochemical and Biophysical Research Communications, 2002
- Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignanciesCancer, 2001
- Cdx1 and Cdx2 expression during intestinal developmentGastroenterology, 2000
- Cloning and chromosome assignment of the human CDX2 geneAnnals of Human Genetics, 1997
- Regulation of lactase–phlorizin hydrolase gene expression by the caudal-related homoeodomain protein Cdx-2Biochemical Journal, 1997
- Structure of the murine homeobox gene cdx-2. Expression in embryonic and adult intestinal epithelium.Journal of Biological Chemistry, 1994
- Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland originCancer, 1987